Conclusion
There is an underappreciation of the contribution of nutritional intake, or lack thereof, to glycemic management in the hospital setting. This chapter has provided an approach to the management of patients on clear liquid and regular diets, in which case the issue of matching insulin dosing to the number of carbohydrates consumed is identical. In addition, we have provided a review of the currently available literature describing approaches to use of pharmacologic glycemic-lowering therapy in patients who are in the fasting state in preparation for surgery or other medical procedures. We described the difficulty in making one recommendation for all insulin-treated patients given the number of different regimens that are prescribed in the greater medical community, with some basal-heavy regimens requiring more significant reductions and some basal-appropriate regimens requiring minimal reductions in dosing. Little data have been published to guide the management of these patients. This means that many of the recommendations reflect consensus opinion that incorporates knowledge of the pharmacokinetics of different insulin and oral preparations, published literature, and extensive personal clinical experience.
References
1. Korytkowski M, Dinardo M, Donihi AC, Bigi L, Devita M. Evolution of a diabetes inpatient safety committee. Endocr Pract 2006;12(Suppl. 3):91–99
2. Draznin B, Gilden J, Golden SH, Inzucchi SE. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807–1814
3. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009;15:353–369
4. Moghissi ES, Korytkowski MT, DiNardo MM, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119–1131
5. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, Seley JJ, Van den Berghe G. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:16–38
6. American Diabetes Association. Diabetes care in the hospital, nursing home, and skilled nursing facility. Diabetes Care 2015;38(Suppl.):S80–S85
7. Joshi GP, Chung F, Vann MA, Ahmad S, Gan TJ, Goulson DT, Merrill DG, Twersky R. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Angalg 2010;111:1378–1387
8. Hirsch IB. Sliding scale insulin—time to stop sliding. JAMA 2009;301:213–214
9. Desimone ME, Blank GE, Virji M, Donihi A, DiNardo M, Simak DM, Buranosky R, Korytkowski MT. Effect of an educational inpatient diabetes management program on medical resident knowledge and measures of glycemic control: A randomized controlled trial. Endocr Pract 2012;18:238–243
10. Cheekati V OR, Jameson KA, Cook CB. Perceptions of resident physicians about management of inpatient hyperglycemia in an urban hospital. J Hosp Med 2009;4:E1–E8
11. Cook CB, Jameson KA, Hartsell ZC, Boyle ME, Leonhardi BJ, Farquhar-Snow M, Beer KA. Beliefs about hospital diabetes and perceived barriers to glucose management among inpatient midlevel practitioners. Diabetes Educ 2008;34:75–83
12. Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, Schnipper JL. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med 2008;3:55–63
13. Wexler DJ, Shrader P, Burns SM, Cagliero E. Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial. Diabetes Care 2010;33:2181–2183
14. Curll M, DiNardo M, Noschese M, Korytkowski MT. Menu selection, glycaemic control, and satisfaction with standard and patient-controlled consistent carbohydrate diet meal plans in hospitalised patients with diabetes. Qual Saf Health Care 2010;19:355
15. DiNardo M, Donihi AC, Forte P, Gieraltowski L, Korytkowski M. Standardized glycemic management and perioperative glycemic outcomes in patients with diabetes mellitus who undergo same-day surgery. Endocr Pract 2011;17:404
16. Ryan DB, Swift CS. The mealtime challenge: nutrition and glycemic control in the hospital. Diabetes Spect 2014;27:163–168
17. DiNardo M, Griffin C, Curll M. Outpatient surgery. A guide for people with diabetes. Diabetes Forecast 2005;58:50–54
18. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK, Group TS. Three-year efficacy of complex insulin regimens in type 2 diabetes. New Engl J Med 2009;361:1736–1747
19. Wallia A, Molitch ME. Insulin therapy for type 2 diabetes mellitus. JAMA 2014;311:2315–2325
20. Dungan KM, Sagrilla C, Abdel-Rasoul M, Osei K. Prandial insulin dosing using the carbohydrate counting technique in hospitalized patients with type 2 diabetes. Diabetes Care 2013;36:3476–3482
21. Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008;14:1095–1101
22. Walsh J, Roberts R, Bailey T. Guidelines for optimal bolus calculator settings in adults. J Diabetes Sci Technol 2011;5:129–135
23. Kuroda A, Yasuda T, Takahara M, Sakamoto F, Kasami R, Miyashita K, Yoshida S, Kondo E, Aihara K, Endo I, Matsuoka TA, Kaneto H, Matsumoto T, Shimomura I, Matsuhisa M. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump. Diabetes Technol Therap 2012;14:1077–1080
24. Noh YH, Lee WJ, Kim KA, Lim I, Lee JH, Lee JH, Kim S, Choi SB. Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion. Diabetes Technol Therap 2010;12:271–281
25. Pelzer R, Mathews EH, Liebenberg L. Preliminary application of a new bolus insulin model for type 1 diabetes. Diabetes Technol Therap 2011;13:527–535
26. King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing. J Diabetes Sci Technol 2007;1:42–46
27. Noschese M, Donihi AC, Koerbel G, Karslioglu E, DiNardo M, Curll M, Korytkowski MT: Effect of a Diabetes Order Set on glycaemic management and control in the hospital. Qual Saf Health Care 2008;17:464–468
28. Ampudia-Blasco FJ, Rossetti P, Ascaso JF. Basal plus basal-bolus approach in type 2 diabetes. Diabetes Technol Therap 2011;13(Suppl. 1):S75–S83
29. Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, Jacobs S, Rizzo M, Peng L, Reyes D, Pinzon I, Fereira ME, Hunt V, Gore A, Toyoshima MT, Fonseca VA. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care 2013;36:2169–2174
30. Donihi AC, DiNardo MM, DeVita MA, Korytkowski MT. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care 2006;15:89–91
31. Umpierrez